TAKANASHI KEN purchased 17.6% of their position (233.33K shares) of SATSUMA PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $3.50M — a significant purchase. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 9/17/2019ACC: 0000899243-19-023732
Director10% Owner
Since Sep 2019
+233.33K
Net shares
Net buyer
$3.50M
Total acquired
1
Open market trades
1B · 0S
5
Total transactions
574.18K acquired · 340.85K disposed
Non-Derivative Transactions3
Common Stock, $0.0001 par value
Indirect
Shares
+33.74K
Price / share
—
Trade value
—
% of position
3.4%
9/17/2019
987.53K→1.02M
Common Stock, $0.0001 par value
Indirect
Shares
+307.11K
Price / share
—
Trade value
—
% of position
30.1%
9/17/2019
1.02M→1.33M
Common Stock, $0.0001 par value
Indirect
Shares
+233.33K
Price / share
$15.00
Trade value
$3.50M
% of position
17.6%
9/17/2019
1.33M→1.56M
Total
Net shares
+574.18K
Net value
$3.50M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 par value Indirect | 9/17/2019 | C · Conversion | +33.74K | — | — | 3.4% | 987.53K | 1.02M |
| Common Stock, $0.0001 par value Indirect | 9/17/2019 | C · Conversion | +307.11K | — | — | 30.1% | 1.02M | 1.33M |
| Common Stock, $0.0001 par value Indirect | 9/17/2019 | P · Purchase | +233.33K | $15.00 | $3.50M | 17.6% | 1.33M | 1.56M |
| Total | +574.18K | $3.50M | ||||||
Derivative Transactions2
Series A Preferred Stock
Indirect
Converts to
Common Stock
33.74K shares
Shares
−33.74K
Strike price
Held after
0.00
Exercisable
—
9/17/2019
Series B Preferred Stock
Indirect
Converts to
Common Stock
307.11K shares
Shares
−307.11K
Strike price
Held after
0.00
Exercisable
—
9/17/2019
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Series A Preferred Stock Indirect | Common Stock33.74K shares | 9/17/2019 | C · Conversion | −33.74K | — | 0.00 | |
| Series B Preferred Stock Indirect | Common Stock307.11K shares | 9/17/2019 | C · Conversion | −307.11K | — | 0.00 |